Annual FCF
$24.62 M
+$45.20 M+219.65%
December 31, 2023
Summary
- As of February 7, 2025, MDXG annual free cash flow is $24.62 million, with the most recent change of +$45.20 million (+219.65%) on December 31, 2023.
- During the last 3 years, MDXG annual FCF has risen by +$59.44 million (+170.71%).
- MDXG annual FCF is now -57.21% below its all-time high of $57.54 million, reached on December 31, 2017.
Performance
MDXG Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$19.45 M
-$1.89 M-8.86%
September 30, 2024
Summary
- As of February 7, 2025, MDXG quarterly free cash flow is $19.45 million, with the most recent change of -$1.89 million (-8.86%) on September 30, 2024.
- Over the past year, MDXG quarterly FCF has increased by +$19.62 million (+11818.67%).
- MDXG quarterly FCF is now -8.86% below its all-time high of $21.34 million, reached on June 30, 2024.
Performance
MDXG Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$50.46 M
+$7.29 M+16.89%
September 30, 2024
Summary
- As of February 7, 2025, MDXG TTM free cash flow is $50.46 million, with the most recent change of +$7.29 million (+16.89%) on September 30, 2024.
- Over the past year, MDXG TTM FCF has increased by +$21.16 million (+72.20%).
- MDXG TTM FCF is now -18.23% below its all-time high of $61.71 million, reached on June 30, 2018.
Performance
MDXG TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MDXG Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +219.7% | +10000.0% | +72.2% |
| 3 y3 years | +170.7% | +288.1% | +829.1% |
| 5 y5 years | -4.5% | +181.7% | +222.6% |
MDXG Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +219.7% | -8.9% | +288.1% | at high | +347.3% |
| 5 y | 5-year | at high | +159.1% | -8.9% | +181.7% | at high | +210.0% |
| alltime | all time | -57.2% | +159.1% | -8.9% | +181.7% | -18.2% | +210.0% |
MiMedx Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $19.45 M(-8.9%) | $50.46 M(+16.9%) |
| Jun 2024 | - | $21.34 M(<-9900.0%) | $43.17 M(+47.3%) |
| Mar 2024 | - | -$166.00 K(-101.7%) | $29.30 M(+18.2%) |
| Dec 2023 | $24.62 M(-219.6%) | $9.83 M(-19.2%) | $24.79 M(+223.3%) |
| Sep 2023 | - | $12.16 M(+62.7%) | $7.67 M(-297.3%) |
| Jun 2023 | - | $7.48 M(-259.7%) | -$3.89 M(-73.6%) |
| Mar 2023 | - | -$4.68 M(-35.8%) | -$14.75 M(-27.7%) |
| Dec 2022 | -$20.58 M(+277.4%) | -$7.29 M(-1295.2%) | -$20.41 M(+22.4%) |
| Sep 2022 | - | $610.00 K(-118.0%) | -$16.67 M(+45.0%) |
| Jun 2022 | - | -$3.38 M(-67.3%) | -$11.50 M(+66.2%) |
| Mar 2022 | - | -$10.34 M(+190.7%) | -$6.92 M(+33.1%) |
| Dec 2021 | -$5.45 M(-84.3%) | -$3.56 M(-161.5%) | -$5.20 M(-63.0%) |
| Sep 2021 | - | $5.78 M(+384.3%) | -$14.06 M(-44.0%) |
| Jun 2021 | - | $1.19 M(-113.9%) | -$25.12 M(-15.8%) |
| Mar 2021 | - | -$8.62 M(-30.6%) | -$29.82 M(-13.5%) |
| Dec 2020 | -$34.82 M(-16.4%) | -$12.42 M(+135.7%) | -$34.49 M(-24.8%) |
| Sep 2020 | - | -$5.27 M(+50.3%) | -$45.89 M(+4.4%) |
| Jun 2020 | - | -$3.51 M(-73.6%) | -$43.93 M(+14.0%) |
| Mar 2020 | - | -$13.29 M(-44.2%) | -$38.55 M(-6.4%) |
| Dec 2019 | -$41.63 M(-261.6%) | -$23.82 M(+618.3%) | -$41.16 M(+133.4%) |
| Sep 2019 | - | -$3.32 M(-276.5%) | -$17.64 M(+35.9%) |
| Jun 2019 | - | $1.88 M(-111.8%) | -$12.98 M(-486.0%) |
| Mar 2019 | - | -$15.91 M(+5292.5%) | $3.36 M(-87.3%) |
| Dec 2018 | $25.77 M(-55.2%) | -$295.00 K(-121.9%) | $26.38 M(-43.2%) |
| Sep 2018 | - | $1.35 M(-92.6%) | $46.41 M(-24.8%) |
| Jun 2018 | - | $18.22 M(+156.3%) | $61.71 M(+11.8%) |
| Mar 2018 | - | $7.11 M(-64.0%) | $55.20 M(-4.5%) |
| Dec 2017 | $57.54 M(+242.5%) | $19.74 M(+18.6%) | $57.81 M(+11.5%) |
| Sep 2017 | - | $16.65 M(+42.1%) | $51.87 M(+42.0%) |
| Jun 2017 | - | $11.71 M(+20.5%) | $36.52 M(+20.4%) |
| Mar 2017 | - | $9.72 M(-29.6%) | $30.35 M(+72.0%) |
| Dec 2016 | $16.80 M(+38.5%) | $13.80 M(+962.1%) | $17.64 M(+169.3%) |
| Sep 2016 | - | $1.30 M(-76.5%) | $6.55 M(-39.9%) |
| Jun 2016 | - | $5.53 M(-285.4%) | $10.90 M(+52.8%) |
| Mar 2016 | - | -$2.98 M(-210.4%) | $7.13 M(-45.1%) |
| Dec 2015 | $12.13 M | $2.71 M(-52.1%) | $12.98 M(-27.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $5.64 M(+219.5%) | $17.83 M(-12.8%) |
| Jun 2015 | - | $1.77 M(-38.3%) | $20.45 M(+6.6%) |
| Mar 2015 | - | $2.86 M(-62.1%) | $19.18 M(+34.7%) |
| Dec 2014 | $13.65 M(-512.4%) | $7.56 M(-8.5%) | $14.24 M(+97.9%) |
| Sep 2014 | - | $8.26 M(+1549.3%) | $7.20 M(-2569.3%) |
| Jun 2014 | - | $501.00 K(-124.1%) | -$291.50 K(-88.5%) |
| Mar 2014 | - | -$2.08 M(-505.8%) | -$2.53 M(-3.6%) |
| Dec 2013 | -$3.31 M(-16.6%) | $512.10 K(-33.8%) | -$2.62 M(-38.2%) |
| Sep 2013 | - | $773.40 K(-144.6%) | -$4.24 M(-29.8%) |
| Jun 2013 | - | -$1.73 M(-20.1%) | -$6.04 M(+25.6%) |
| Mar 2013 | - | -$2.17 M(+96.4%) | -$4.81 M(+21.1%) |
| Dec 2012 | -$3.97 M(-44.5%) | -$1.11 M(+7.8%) | -$3.97 M(-13.5%) |
| Sep 2012 | - | -$1.03 M(+104.1%) | -$4.59 M(-6.9%) |
| Jun 2012 | - | -$502.60 K(-62.3%) | -$4.93 M(-25.2%) |
| Mar 2012 | - | -$1.33 M(-22.6%) | -$6.58 M(-7.9%) |
| Dec 2011 | -$7.15 M(-13.9%) | -$1.72 M(+26.4%) | -$7.15 M(-3.6%) |
| Sep 2011 | - | -$1.36 M(-36.9%) | -$7.42 M(-11.2%) |
| Jun 2011 | - | -$2.16 M(+13.6%) | -$8.35 M(+0.6%) |
| Mar 2011 | - | -$1.90 M(-4.4%) | -$8.30 M(-0.1%) |
| Dec 2010 | -$8.31 M(+48.2%) | -$1.99 M(-13.5%) | -$8.31 M(+31.5%) |
| Sep 2010 | - | -$2.30 M(+9.1%) | -$6.32 M(+6.6%) |
| Jun 2010 | - | -$2.11 M(+10.2%) | -$5.93 M(+6.3%) |
| Mar 2010 | - | -$1.91 M(+0.1%) | -$5.58 M(-22.6%) |
| Dec 2009 | -$5.61 M(-37.1%) | - | - |
| Sep 2009 | - | -$1.91 M(+8.6%) | -$7.21 M(-7.6%) |
| Jun 2009 | - | -$1.76 M(+29.1%) | -$7.80 M(-12.5%) |
| Mar 2009 | - | -$1.36 M(-37.5%) | -$8.92 M(+18.0%) |
| Mar 2009 | -$8.92 M(-4.2%) | - | - |
| Dec 2008 | - | -$2.18 M(-12.9%) | -$7.55 M(+40.5%) |
| Sep 2008 | - | -$2.50 M(-12.8%) | -$5.38 M(+86.2%) |
| Jun 2008 | - | -$2.87 M(>+9900.0%) | -$2.89 M(>+9900.0%) |
| Mar 2008 | -$9.31 M(>+9900.0%) | - | - |
| Dec 2007 | -$23.70 K(+0.4%) | -$2800.00(-80.3%) | -$23.70 K(+13.4%) |
| Sep 2007 | - | -$14.20 K(+576.2%) | -$20.90 K(+211.9%) |
| Jun 2007 | - | -$2100.00(-54.3%) | -$6700.00(+45.7%) |
| Mar 2007 | - | -$4600.00 | -$4600.00 |
| Dec 2006 | -$23.60 K | - | - |
FAQ
- What is MiMedx annual free cash flow?
- What is the all time high annual FCF for MiMedx?
- What is MiMedx annual FCF year-on-year change?
- What is MiMedx quarterly free cash flow?
- What is the all time high quarterly FCF for MiMedx?
- What is MiMedx quarterly FCF year-on-year change?
- What is MiMedx TTM free cash flow?
- What is the all time high TTM FCF for MiMedx?
- What is MiMedx TTM FCF year-on-year change?
What is MiMedx annual free cash flow?
The current annual FCF of MDXG is $24.62 M
What is the all time high annual FCF for MiMedx?
MiMedx all-time high annual free cash flow is $57.54 M
What is MiMedx annual FCF year-on-year change?
Over the past year, MDXG annual free cash flow has changed by +$45.20 M (+219.65%)
What is MiMedx quarterly free cash flow?
The current quarterly FCF of MDXG is $19.45 M
What is the all time high quarterly FCF for MiMedx?
MiMedx all-time high quarterly free cash flow is $21.34 M
What is MiMedx quarterly FCF year-on-year change?
Over the past year, MDXG quarterly free cash flow has changed by +$19.62 M (+11818.67%)
What is MiMedx TTM free cash flow?
The current TTM FCF of MDXG is $50.46 M
What is the all time high TTM FCF for MiMedx?
MiMedx all-time high TTM free cash flow is $61.71 M
What is MiMedx TTM FCF year-on-year change?
Over the past year, MDXG TTM free cash flow has changed by +$21.16 M (+72.20%)